GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Interest Expense (Positive)

AdAlta (ASX:1AD) Interest Expense (Positive)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


AdAlta Business Description

Industry
Traded in Other Exchanges
N/A
Address
Science Drive, La Trobe Institute for Molecular Science, Room 204, LIMS2, La Trobe University, Bundoora, VIC, AUS, 3086
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.